Alliance for Multispecialty Research, LLC | AMR Wichita East, KS
Status and phase
Conditions
Treatments
Study type
Funder types
Identifiers
About
The purpose of this clinical trial is to learn about the safety, extent of the side effects, and immune responses of the study vaccine (called variant-adapted BNT162b2 RNA-based vaccine) in healthy children. The trial is divided into 5 individual studies or substudies based on age group and prior history of COVID-19 vaccinations. All participants in each of the 5 sub-studies will receive study vaccine as a shot depending on what group they are in.
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Substudy A
Inclusion Criteria:
Exclusion Criteria:
Substudy B
Inclusion Criteria:
Exclusion Criteria:
Substudy C
Inclusion Criteria:
Exclusion Criteria:
Substudy D
Inclusion Criteria:
Exclusion Criteria:
Substudy E
Inclusion Criteria:
Exclusion Criteria:
Primary purpose
Allocation
Interventional model
Masking
3,692 participants in 23 patient groups
Loading...
Central trial contact
Pfizer CT.gov Call Center
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal